Berlin-based accelerator and advisory firm, Ampion, has partnered with American pharmaceutical company, Merck, to launch a health accelerator programme in Africa.
The health accelerator’s objective is to nurture the development of high potential and early-stage eHealth startups trying to solve healthcare issues such as HIV, Ebola and Diabetes.
“The launch of the first healthcare accelerator in Africa is designed to be a major boost to healthcare innovation on the continent.” said Alexander Hoffmann, Merck project manager in a Disrupt Africa report, “Africa has many of the fastest growing technology markets worldwide.”
The accelerator will provide selected startups with support, mentorship and a platform to network with key global players from the Merck’s headquarters innovation centre in Damstardt, Germany. It will operate out of Nairobi and will start accepting applications from eHealth startups by September 1, 2015 to its programme on a rolling basis.
Ampion is accepting applications from startups for its Venture Buses 2015 roadtrip, a five-day competition and road trip for African change makers and tech experts, which travel across Morocco, Tunisia, East/West and Southern Africa.
Credit: Skeeze via Pixabay
